Annual report pursuant to Section 13 and 15(d)

Cover

v3.24.1
Cover - USD ($)
 12 Months Ended
Dec. 31, 2023
Mar. 22, 2024
Jun. 30, 2023
Cover [Abstract]      
Entity Registrant Name Artelo Biosciences, Inc.    
Entity Central Index Key 0001621221    
Document Type 10-K    
Amendment Flag false    
Entity Voluntary Filers No    
Current Fiscal Year End Date --12-31    
Entity Well Known Seasoned Issuer No    
Entity Small Business true    
Entity Shell Company false    
Entity Emerging Growth Company false    
Entity Current Reporting Status Yes    
Document Period End Date Dec. 31, 2023    
Entity Filer Category Non-accelerated Filer    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2023    
Entity Common Stock Shares Outstanding   3,227,700  
Entity Public Float     $ 5,629,634
Document Annual Report true    
Document Transition Report false    
Document Fin Stmt Error Correction Flag false    
Entity File Number 001-38951    
Entity Incorporation State Country Code NV    
Entity Tax Identification Number 33-1220924    
Entity Address Address Line 1 505 Lomas Santa Fe    
Entity Address Address Line 2 Suite 160    
Entity Address City Or Town Solana Beach    
Entity Address State Or Province CA    
Entity Address Country US    
Entity Address Postal Zip Code 92075    
City Area Code 858    
Icfr Auditor Attestation Flag false    
Auditor Firm Id 206    
Local Phone Number 925-7049    
Security 12b Title Common Stock, $0.001 par value per share    
Trading Symbol ARTL    
Security Exchange Name NASDAQ    
Entity Interactive Data Current Yes    
Auditor Name MaloneBailey, LLP    
Auditor Location Houston, Texas